PharmaPre-market
Innova Captab targets 25% revenue growth with ₹300 crore capex
pre-market1 source ↓written by the desknot a recommendation
- target
- 25% revenue growth
- capital expenditure plan
- ₹300 crore
Innova Captab Limited has announced a 25% revenue growth target, supported by a ₹300 crore capital expenditure plan. The investment will focus on expanding its Contract Development and Manufacturing Organization (CDMO) business and entering regulated markets.
Key Points:
• CDMO expansion to enhance production capabilities
• Plans to strengthen API production and increase formulation exports
• Targeting growth in the high-value oncology segment
This strategy may bolster investor confidence and enhance market positioning.
Not investment advice. For informational purposes only.